Martingale Asset Management L P Homology Medicines, Inc. Transaction History

Martingale Asset Management L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.64 - $7.78 $55,764 - $119,189	-15,320 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.01 - $8.71 $92,073 - $133,437	15,320 New	15,320 $0
Q2 2021 Aug 13, 2021	SELL	$6.02 - $9.64 $107,860 - $172,719	-17,917 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$8.92 - $13.29 $694,823 - $1.04 Million	-77,895 Reduced 81.3%	17,917 $0
Q3 2020 Nov 12, 2020	SELL	$9.94 - $16.59 $488,054 - $814,569	-49,100 Reduced 33.88%	95,812 $0

Q2 2020 Aug 10, 2020	BUY	$12.07 - $19.34 $1.75 Million - $2.8 Million	144,912 New	144,912 $0

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.